期刊文献+

血清Chemerin在糖尿病视网膜病变患者中的表达及临床意义 被引量:7

Expression of serum Chemerin in the diabetic retinopathy patients and its clinical implication
下载PDF
导出
摘要 目的:观察糖尿病视网膜病变( diabetic retinopathy,DR)患者血清Chemerin 水平变化,探讨其在DR发生发展过程中的作用。 方法:采用临床病例对照研究,以2012-01/2013-12期间就诊的90例糖尿病患者为研究对象,分为糖尿病无视网膜病变( no diabetic retinopathy,NDR)组、单纯型糖尿病视网膜病变( simple diabetic retinopathy,SDR)组和增殖型糖尿病视网膜病变( proliferative diabetic retmopathy,PDR)组三组,以健康志愿者( normal controls,NC)为对照组,采用双抗体夹心法酶联免疫吸附法检测患者血清中Chemerin水平,同时检测TNF-α、脂联素等炎症因子水平,收集患者体重指数、血脂、基础疾病等临床资料。 结果:NC 组、NDR 组、SDR 组和 PDR 组患者血清Chemerin±次为12.35±3.56、26.50±5.34、34.67±7.72、40.97±8.97μg/L,SDR组、PDR血清Chemerin水平明显高于NC组和NDR组,差异有统计学意义( P〈0.01),血清Chemerin水平与TNF-α正相关(r=0.8746,P〈0.01),与脂联素负相关(r=-0.7418,P〈0.01)。 Logistic多元回归分析结果显示,Chemerin为DR独立危险因素之一( OR=8.458,95%CI:1.611~44.410,P=0.012)。 结论:DR患者血清中Chemerin水平升高,其可能参与了DR的发生发展过程。 AIM: To investigate the level changes of serum Chemerin in patients with diabetic retinopathy ( DR) and explore its role in the development of DR. METHODS: A total of 90 diabetes patients from January 2012 to December 2013 were enrolled, including non-diabetic retinopathy (NDR,n=30), simple diabetic retinopathy ( SDR, n = 30 ) , proliferative diabetic retinopathy ( PDR, n=30 ) . Thirty healthy persons were included as normal control ( NC) . Chemerin level, tumor necrosis factor-α ( TNF-α) , adiponectin were assessed by enzyme - linked immunosorbent assay. Clinical characters including BMI, underlying diseases, blood lipids ect. were collected. RESULTS:The serum levels of Chemerin in NC, NDR, SDR, and PDR group were 12. 35±3. 56, 26. 50±5. 34, 34. 67±7. 72, 40. 97±8. 97μg/L respectively. The serum levels of Chemerin in SDR and PDR group were significantly higher than those in NC and NDR group(P〈0. 01). Serum levels of Chemerin positively correlated with TNF-α ( r=0.8746, P 〈 0. 01 ) and negatively correlated with adiponectin (r=-0. 7418,P〈0. 01). The results of Logistic regression analysis showed that Chemerin was an independent risk factor for DR (OR=8. 458, 95%CI:1.611~44. 410, P=0. 012). CONCLUSION:The results show that serum Chemerin level is significantly elevated in DR patients, and Chemerin may be involved in the development of DR.
出处 《国际眼科杂志》 CAS 2015年第10期1717-1719,共3页 International Eye Science
关键词 糖尿病视网膜病变 CHEMERIN 糖尿病 diabetic retinopathy Chemerin diabetes mellitus
  • 相关文献

参考文献15

  • 1Aveleira CA, Lin CM, Abcouwer SF, et al. TNF-cL signals through PKC/NF-KB to alter the tight junction complex and increase retinal endothelial cell ermeability. Diabetes ,2010 ,59 ( 11 ) :2872-2782.
  • 2Neuparth MJ, Proena JB, Santos-Silva A, et al. The positive effect of moderate walking exercise on chemerin levels in Portuguese patients with type 2 diabetes mellitus. J Cell Mol Med ,2014 , 18 (7) : 1313-13,20.
  • 3谢明捷,吕红彬,何跃,赵春会.炎症因子与糖尿病视网膜病变相关性研究进展[J].眼科新进展,2012,32(10):990-993. 被引量:16
  • 4李春深,苗戎,蔡青,周涛,谭俊珍,武学润,常柏.ICAM-1和VCAM-1在糖尿病视网膜病变中的作用(英文)[J].国际眼科杂志,2012,12(1):1-3. 被引量:9
  • 5Rifat Rasier,Ozgur Artunay,Uzay Gormus,Erdal Yuzbasioglu,Alper Sengul,Amber Senel Kukner,Murat Oncel,Halil Bahcecioglu.糖尿病视网膜病变患者玻璃体样本中白细胞介素-8和肿瘤坏死因子-α水平(英文)[J].国际眼科杂志,2013,13(12):2365-2369. 被引量:10
  • 6Fiil6p P, Seres I, Lrincz H, et al. Association of chemefin with oxidative stress, inflammation and classical adipokines in non-diabetic obese patients. J Cell Mol Meal,18(7) :1313-13,20.
  • 7Herenius MM, Oliveira AS, Wijbrandts CA, et al. Anti-TNF therapy reduces serum levels of chemerin in rheumatoid arthritis: a new mechanism by which anti-TNF might reduce inflammation. PLoS One ,2013,8(2) : e57802.
  • 8Studholme S. Diabetic retinopathy. J Perioper Pract ,2008 , ( 5 ) : ,205-210.
  • 9Segersvard R, Tsai JA, Herrington MK, et al. Obesity alters cytokine gene expression and promotes liver injury in rats with acute pancreatitis. Obesity ( Silver Spring) ,2008 , 16( 1 ) :23-28.
  • 10Bozaoglu K, Bohon K, McMillan J, et al . Chemerin is a novel adipokine associated with obesity and metabolic syndrome. Endocrinology ,2007 , 148 ( 10 ) :4687-4694.

二级参考文献32

  • 1Shuang Li,Xun-An Fu,Xiao-Fang Zhou,You-Yan Chen,Wei-Qun Chen.Angiogenesis-related cytokines in serum of proliferative diabetic retinopathy patients before and after vitrectomy[J].International Journal of Ophthalmology(English edition),2012,5(6):726-730. 被引量:9
  • 2Kern TS.Contributions of inflammatory processes to the development of the early stages of diabetic retinopathy.Exp Diabetes Revs 2007;2007:95103.
  • 3Khalfaoui T,Lizard G,Ouertani-Meddeb A.Adhesion molecules (ICAM-1 and VCAM-1) and diabetic retinopathy in type 2 diabetes.J Mol Histol 2008;39(2):243-249.
  • 4Goldberg RB.Cytokine and cytokine-like inflammation markers,endothelial dysfunction,and imbalanced coagulation in development of diabetes and its complications.J Clin Endocrinal Metab 2009;94(9):3171-3182.
  • 5Van Buul JD,Kanters E,Hordijk PL.Endothelial signaling by Ig-like cell adhesion molecules.Arterioscler Thromb Vasc Biol 2007;27:1870-1876.
  • 6Gustavsson C,Agardh CD,Zetterqvist AV,Nilsson J,Agardh E,Gomez MF.Vascular cellular adhesion molecule-1 (VCAM-1) expression in mice retinal vessels is affected by both hyperglycemia and hyperlipidemia.PLoS One 2010:5(9):e12699.
  • 7El-Remessy AB,Al-Shabrawey M,Khalifa Y,Tsai NT,Caldwell RB,Liou GI.Neuroprotective and blood-retinal barrier-preserving effects of cannabidiol in experimental diabetes.Am J Pathol 2006;168(1):235-244.
  • 8McLeod DS,Lefer DJ.Enhanced expression of intracellular adhesion molecule-1 and P-selectin in the diabetic human retina and choroid.Am J Pathol 1995;147(3):642-653.
  • 9Limb GA,Hickman-Casey J,Hollifield RD,Chignell AH.Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy.Invest Ophthalmol Vis Sci 1999;40(10):2453-2457.
  • 10Hernandez C,Burgos R,Canton A,García-Arumí J,Segura RM,Simó R.Vitreous levels of vascular cell adhesion molecule and vascular endothelial growth factor in patients with proliferative diabetic retinopathy:a case-control study.Diabetes Care 2001;24(3):516-521.

共引文献32

同被引文献51

引证文献7

二级引证文献29

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部